chronic disease – Benefits Canada.com https://www.benefitscanada.com Canada's most influential pension and benefits publication for decision-makers Thu, 21 Nov 2024 16:43:00 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.8 Cancer treatments represented a third of medicines in clinical trials in 2023: report https://www.benefitscanada.com/benefits/health-benefits/cancer-treatments-represented-a-third-of-medicines-in-clinical-trials-in-2023-report/ Fri, 15 Nov 2024 14:00:04 +0000 https://www.benefitscanada.com/?p=162782 Cancer treatments represented 33 per cent of medicines in all phases of clinical trials in 2023, followed by treatments for infectious diseases (13 per cent) and central nervous system diseases (12 per cent), according to a new report by the Patented Medicine Prices Review Board. It found more than 12,000 new medicines were undergoing clinical […]

The post Cancer treatments represented a third of medicines in clinical trials in 2023: report appeared first on Benefits Canada.com.

]]> How benefits plan sponsors, insurers are managing newer — and effective — GLP-1 medications https://www.benefitscanada.com/archives_/benefits-canada-archive/how-benefits-plan-sponsors-insurers-are-managing-newer-and-effective-glp-1-medications/ Fri, 15 Nov 2024 13:55:00 +0000 https://www.benefitscanada.com/?p=162339 With lyrics adapted to the tune of ‘Magic’ by Scottish pop group Pilot, the melody of ‘Oh, Oh, Oh, Ozempic’ is splashed across U.S. televisions in a snappy advertising campaign. The commercial push is likely unnecessary. Ozempic, one of the brand names of a glucagon-like peptide-1 receptor agonist medication used to treat type 2 diabetes, […]

The post How benefits plan sponsors, insurers are managing newer — and effective — GLP-1 medications appeared first on Benefits Canada.com.

]]> Plan members’ financial strain a call to action for plan sponsors: 2024 BCHS report launch https://www.benefitscanada.com/benefits/health-wellness/plan-members-financial-strain-a-call-to-action-for-plan-sponsors-2024-bchs-report-launch/ Mon, 23 Sep 2024 13:00:30 +0000 https://www.benefitscanada.com/?p=160368 Canadian health benefits plan members are increasingly feeling financially strained, according to the 2024 Benefits Canada Healthcare Survey — a finding that experts say should be a call to action to employers to include more financial wellness supports in benefits plans. Personal finances has remained plan members’ top stressor for the past two years, with […]

The post Plan members’ financial strain a call to action for plan sponsors: 2024 BCHS report launch appeared first on Benefits Canada.com.

]]> How plan sponsors, insurers should approach Wegovy rollout in Canada https://www.benefitscanada.com/benefits/health-benefits/how-plan-sponsors-insurers-should-approach-wegovy-rollout-in-canada/ Wed, 12 Jun 2024 13:00:04 +0000 https://www.benefitscanada.com/?p=156755 When considering whether to cover Wegovy, an obesity medication, it’s important for plan sponsors to weigh increased short-term costs with long-term savings, while considering alternative treatments that are also available, says Philippe Laplante, a principal at Eckler Ltd. Plan sponsors that decide to cover Wegovy, which launched in Canada last month, could see a significant cost […]

The post How plan sponsors, insurers should approach Wegovy rollout in Canada appeared first on Benefits Canada.com.

]]> What plan sponsors should know ahead of rollout of new obesity drugs in Canada https://www.benefitscanada.com/benefits/health-benefits/what-plan-sponsors-should-know-ahead-of-rollout-of-new-obesity-drugs-in-canada/ Mon, 01 Apr 2024 13:00:03 +0000 https://www.benefitscanada.com/?p=153707 A new generation of glucagon-like peptide-1 drugs approved for the treatment of obesity will soon be available in Canada, presenting an opportunity for plan sponsors to meet members’ health and wellness needs. It’s important for employers to consider meeting with their insurer now to find out how the rollout of these drugs will affect their […]

The post What plan sponsors should know ahead of rollout of new obesity drugs in Canada appeared first on Benefits Canada.com.

]]> Plan members with Alzheimer’s still have plenty to offer the workplace: patient advocate https://www.benefitscanada.com/events/conference-coverage/plan-members-with-alzheimers-still-have-plenty-to-offer-the-workplace-patient-advocate/ Mon, 11 Mar 2024 11:58:47 +0000 https://www.benefitscanada.com/?p=152657 After her husband Mike Kessler was diagnosed with mild Alzheimer’s disease in 2021, Karen Kessler admitted she would hover around him. The Windsor, Ont. couple implemented many strategies in place to manage Mike’s diagnosis, and Karen remembers believing he would need plenty of help. “I was doing everything, I was carrying the load, and quite […]

The post Plan members with Alzheimer’s still have plenty to offer the workplace: patient advocate appeared first on Benefits Canada.com.

]]> What employers need to know about pulmonary arterial hypertension https://www.benefitscanada.com/events/conference-coverage/what-employers-need-to-know-about-pulmonary-arterial-hypertension/ Mon, 11 Mar 2024 11:57:13 +0000 https://www.benefitscanada.com/?p=152726 Employees with pulmonary arterial hypertension can experience significant impacts to their quality of life and workplace experience, said John Granton, a respirologist with the University Health Network in Toronto, during a session at Benefits Canada’s 2024 Chronic Disease at Work conference in February. Pulmonary arterial hypertension is a very rare condition, affecting less than 10,000 Canadians. It’s […]

The post What employers need to know about pulmonary arterial hypertension appeared first on Benefits Canada.com.

]]> Webinar coverage: Exploring the role of pharmacists in diagnosing, managing diabetes https://www.benefitscanada.com/benefits/health-benefits/webinar-coverage-exploring-the-role-of-pharmacists-in-diagnosing-managing-diabetes/ Wed, 07 Feb 2024 14:00:53 +0000 https://www.benefitscanada.com/?p=151575 Amid an increase in diabetes diagnoses among Canadians, pharmacists can play a greater role in employers’ and private payers’ chronic disease prevention and management strategies given their increasing scope of practice, said representatives for Health Solutions by Shoppers, during a webinar hosted by Benefits Canada and sponsored by Health Solutions by Shoppers in January. As […]

The post Webinar coverage: Exploring the role of pharmacists in diagnosing, managing diabetes appeared first on Benefits Canada.com.

]]> Highest-cost drugs reimbursed by Canadian public plans in 2021/22 were rare disease treatments: report https://www.benefitscanada.com/benefits/health-benefits/highest-cost-drugs-reimbursed-by-canadian-public-plans-in-2021-22-were-rare-disease-treatments-report/ Tue, 09 Jan 2024 14:00:15 +0000 https://www.benefitscanada.com/?p=149971 The 10 highest-cost drugs reimbursed by public drug plans in Canada in the 2021/22 fiscal year were all rare disease treatments with annual treatment costs of more than $250,000, according to a new report by the Patented Medicine Prices Review Board. It found the increased use of high-cost drugs continued to be the main factor […]

The post Highest-cost drugs reimbursed by Canadian public plans in 2021/22 were rare disease treatments: report appeared first on Benefits Canada.com.

]]> My Take: Obesity should be treated like other chronic conditions under benefits plans https://www.benefitscanada.com/benefits/health-benefits/my-take-obesity-should-be-treated-like-other-chronic-conditions-under-benefits-plans/ Wed, 03 Jan 2024 14:00:46 +0000 https://www.benefitscanada.com/?p=149385 As someone who has become increasingly overweight in the last few years, every time I read or write about obesity being referred to as a ‘lifestyle condition’ it makes me physically cringe. Yes, some poor diet choices have contributed to my current physical condition, but it’s much more complex than that. And I know others […]

The post My Take: Obesity should be treated like other chronic conditions under benefits plans appeared first on Benefits Canada.com.

]]>